Explore more publications!
Health Reporter French Polynesia
Got News to Share?

Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 15, 2025

Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones
December 15, 2025

Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones

Indeterminate GlobeNewswire
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
December 15, 2025

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

Indeterminate GlobeNewswire
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
December 15, 2025

Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST

Indeterminate GlobeNewswire
XOMA Royalty Enters into Agreement to Acquire Generation Bio
December 15, 2025

XOMA Royalty Enters into Agreement to Acquire Generation Bio

Indeterminate GlobeNewswire
Cellectis Announces Arbitral Decision in Dispute with Servier
December 15, 2025

Cellectis Announces Arbitral Decision in Dispute with Servier

Indeterminate GlobeNewswire
Cellectis annonce la décision du tribunal arbitral dans le litige l’opposant à Servier
December 15, 2025

Cellectis annonce la décision du tribunal arbitral dans le litige l’opposant à Servier

Indeterminate GlobeNewswire
BioSyent Announces Renewal of Normal Course Issuer Bid
December 15, 2025

BioSyent Announces Renewal of Normal Course Issuer Bid

Indeterminate GlobeNewswire
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
December 15, 2025

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Indeterminate GlobeNewswire
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2025

Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 15, 2025

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Abivax Presents Third Quarter 2025 Financial Results
December 15, 2025

Abivax Presents Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
December 15, 2025

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025

Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 15, 2025

IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

Indeterminate GlobeNewswire
Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results
December 15, 2025

Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results

Indeterminate GlobeNewswire
Kyverna Therapeutics Announces Proposed Public Offering of Common Stock
December 15, 2025

Kyverna Therapeutics Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
FHSU’s Hybrid BSN Program expands access to nursing education
December 15, 2025

FHSU’s Hybrid BSN Program expands access to nursing education

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
December 15, 2025

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
December 15, 2025

AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers

Indeterminate GlobeNewswire
AB Science annonce une nouvelle publication sur biorxiv identifiant AB8939 comme un candidat médicament prometteur pour le traitement de la leucémie myéloïde aiguë réfractaire et potentiellement d'autres cancers
December 15, 2025

AB Science annonce une nouvelle publication sur biorxiv identifiant AB8939 comme un candidat médicament prometteur pour le traitement de la leucémie myéloïde aiguë réfractaire et potentiellement d'autres cancers

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions